Ratings Cardlytics, Inc.

Equities

CDLX

US14161W1053

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-29 EDT			5-day change	1st Jan Change
12.95 ^USD	+5.20%		+2.94%	+40.61%

04-25	Cardlytics Insider Sold Shares Worth $278,885, According to a Recent SEC Filing	MT
04-09	Cardlytics, Inc. Appoints Liane Hornsey to Its Board of Directors	CI

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.
The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.

Strengths

Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Analyst opinion has improved significantly over the past four months.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company has insufficient levels of profitability.
The valuation of the company is particularly high given the cash flows generated by its activity.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Software

	1st Jan change	Capi.	ESG Refinitiv
CARDLYTICS, INC.	+40.61%	593M	D+
MICROSOFT CORPORATION	+6.97%	3,020B	C+
SYNOPSYS INC.	+5.80%	82.93B	B
CADENCE DESIGN SYSTEMS, INC.	+3.72%	76.85B	B+
DASSAULT SYSTÈMES SE	-15.18%	53.04B	B+
PALANTIR TECHNOLOGIES INC.	+32.96%	50.15B	D+
ATLASSIAN CORPORATION	-25.56%	46.71B	B-
THE TRADE DESK, INC.	+17.43%	41.41B	D+
SEA LIMITED	+59.31%	36.1B	D+
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-10.36%	24.64B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes